Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice
The DOI matches its Crossref record.
Abstract
K‐ras codon 12 mutation is more oncogenic in in vitro and in vivo experimental systems than Kras codon 13 mutation. Moreover, human colorectal tumors bearing a codon 12 mutation are more aggressive, invasive, and metastatic than the same tumor types carrying a codon 13 mutation. However, despite the association between specific sarcoma types and codon 12 or codon 13 mutations, the relationship between the position of the mutated codon at ras genes and tumor aggressiveness has not been studied in this tumor type. Here, we used a nude mice model to evaluate the tumorogenic capacity of stable transfectants of NIH3T3 fibroblasts, expressing Kras mutated at codon 12 (K12) or 13 (K13), and morphologically, functionally, and molecularly compared these tumors. We found histopathological differences between them, K12‐derived tumors showing fibrosarcoma‐like features, whereas K13‐derived tumors resembled malignant fibrous histiocytomas. Moreover, K12 tumors showed shorter latency of appearance, lower apoptotic and mitotic rates, and higher expression of markers for sarcoma aggressiveness (Ki67, p53 and c‐myc) than K13 tumors. They also showed differences in the expression or activation of Ras, Ras downstream pathways [c‐Jun N‐terminal kinase (JNK), MAPK and AKT], and apoptotic [AKT, Bcl‐2, Focal adhesion kinase (FAK)] and mitotic (cyclin B1) regulators, which could explain their functional differences. Most remarkably, the significantly diminished apoptotic rate observed in K12‐derived tumors was associated with enhanced antiapoptotic signaling through the AKT pathway. These morphological, functional, and molecular differences demonstrate that codon 12 and codon 13 mutations in the K‐ras oncogene can induce two different soft tissue sarcoma types in our in vivo model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
NMR-based functional profiling of RASopathies and oncogenic RAS mutations
Smith, M. J., Neel, B. G., & Ikura, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218173110 · Cited by 257
“Recent clinical data reveal a codon-dependent efficacy for drugs targeting RAS-driven tumors, further substantiating that the individual biochemical properties of these mutants play a vital role in tumor pathology (12, 35).”
BackgroundPeeters, M., Douillard, J.-Y., Van Cutsem, E., Siena, S., Zhang, K., Williams, R., & Wiezorek, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.1492 · Cited by 232
Johnson, C. W., Lin, Y.-J., Reid, D., Parker, J., Pavlopoulos, S., Dischinger, P., Graveel, C., Aguirre, A. J., Steensma, M., Haigis, K. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.026 · Cited by 89
Cespedes, M. V., Sancho, F. J., Guerrero, S., Parreno, M., Casanova, I., Pavon, M. A., Marcuello, E., Trias, M., Cascante, M., Capella, G., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl063 · Cited by 67
Self-citation
Metadata
- Authors
- Guerrero, S., Figueras, A., Casanova, I., Farré, L., Lloveras, B., Capellà, G., Trias, M., & Mangues, R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-08-07
- Volume
- 16
- Issue
- 12
- Pages
- 1642-1644
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2116584011
- Cited by
- 41
- References
- 0
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice. https://app.cochat.ai/papers/10.1096/fj.02-0050fje
- The paper
- Guerrero, S., Figueras, A., Casanova, I., Farré, L., Lloveras, B., Capellà, G., Trias, M., & Mangues, R. (2002). Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice. The FASEB Journal. https://doi.org/10.1096/fj.02-0050fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.